Interpretation of guideline for breast cancer screening in Chinese women
10.3969/j.issn.1000-8179.2019.09.581
- VernacularTitle:《中国女性乳腺癌筛查指南》解读(精简版)
- Author:
Yubei HUANG
1
;
Zhongsheng TONG
;
Kexin CHEN
;
Ying WANG
;
Peifang LIU
;
Lin GU
;
Juntian LIU
;
Jinpu YU
;
Fengju SONG
;
Wenhua ZHAO
;
Yehui SHI
;
Hui LI
;
Huaiyuan XIAO
;
Xishan HAO
Author Information
1. 天津医科大学肿瘤医院
- Keywords:
breast cancer;
screening;
guideline
- From:
Chinese Journal of Clinical Oncology
2019;46(9):433-441
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer is the most common cancer for Chinese women. Early screening is the best way to improve the rates of early diagnosis and early treatment of breast cancer. The peak ages of breast cancer in Chinese women are obviously different from those in the European and American countries. It is imperative to develop a guideline for breast cancer screening that is suitable for Chinese women. Based on the analysis and summary of breast cancer screening data in China, and the latest guidelines and consensus on breast cancer screening in Europe, the United States and East Asia, China Anti-Cancer Association and National Clinical Research Center for Cancer (Tianjin Medical University Cancer Institute and Hospital) has developed a population-based guideline for breast cancer screening in Chinese women. This guideline has provided detailed recommendations on the screening starting age, screening modalities, and screening interval in Chinese women with average risk and high risk of breast cancer, respectively. This article aims to interpret the above guideline, providing references for professionals in breast cancer screening.
